Osmotica Pharmaceuticals plc Note Agreements
3 Contracts & Agreements
- Third Amendment to Note Purchase Agreement, dated August 13, 2023, by and among RevitaLid Pharmaceutical Corp., the Guarantors party thereto, the Purchasers party thereto and... (Filed With SEC on August 14, 2023)
- Second Amendment to Note Purchase Agreement, dated March 8, 2023, by and among RevitaLid (Filed With SEC on March 20, 2023)
- Note Purchase Agreement dated October 1, 2021, between Osmotica Pharmaceutical Corp., Osmotica Pharmaceuticals plc, Osmotica Holdings US LLC, Athyrium Opportunities IV Acquisition... (Filed With SEC on October 6, 2021)